GENNEX LABORATORIES
Back to Cashflow Statement
|
GENNEX LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-64 Cr | ₹-11 Cr | ₹-47 Cr | ₹24 Cr | ₹12 Cr |
What is the latest Cash Flow from Operating Activities ratio of GENNEX LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹-64 Cr |
| Mar2025 | ₹-11 Cr |
| Mar2024 | ₹-47 Cr |
| Mar2023 | ₹24 Cr |
| Mar2022 | ₹12 Cr |
How is Cash Flow from Operating Activities of GENNEX LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-64 Cr | Negative | |
| Mar2025 | ₹-11 Cr | Negative | |
| Mar2024 | ₹-47 Cr | Negative | |
| Mar2023 | ₹24 Cr | 98.82 | |
| Mar2022 | ₹12 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹217.6 Cr | -4.5% | -6.8% | -39.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -4.5% |
-6.8% |
-39.7% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses